Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
52-Week Open-Label Extension and Safety Study of Pitavastatin in High-Risk Hyperlipidaemia in Childhood
2011-004983-32Phase 3Completed
- Sponsor
- Kowa Research Europe
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pitavastatin in hyperlipidemia and familial hypercholesterolemia (FH), sponsored by Kowa Research Europe. Primary endpoint: Adverse events. Started Feb 2012; status: completed.
02
Drugs
pitavastatin
03
Conditions
hyperlipidemiafamilial hypercholesterolemia (FH)
Beyond the preview
Go deeper on 2011-004983-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004983-32.